SUNNYVALE, California, March 4, 2013 /PRNewswire/ --
Accuray Incorporated (Nasdaq: ARAY), today announced highlights from the First European Conference on stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) and image-guided intensity-modulated radiation therapy (IG-IMRT), hosted in partnership with the Istituto Europeo di Oncologia Milano and the Università degli studi di Milano, held in Milan, Italy on February 22-23, 2013.
The conference "Radiation Oncology: can we still treat without image guidance?" was attended by more than 400 healthcare professionals, including radiation oncologists, medical physicists and hospital administrators from 32 countries. Outcomes of recent research in areas such as central nervous system (CNS), head and neck, breast, lung, gastrointestinal (GI), pelvis, total marrow irradiation (TMI) and pediatrics were presented.
The independent Scientific Committee, led by Prof. Roberto Orecchia (Istituto Europeo di Oncologia Milano, Italy) and Prof. Eric Lartigau (Centre Oscar Lambret, Lille, France), focused on new developments in the field and developed an educational event to discuss the need of image guidance for a variety of clinical indications in modern radiation therapy. "Daily image guidance is crucial for all high-precision treatments, also for palliative treatments" said Prof. Eric Lartigau."The TomoTherapy® System provides an automatic process that makes our daily work easy" said Prof. Dirk Verellen, UZ Brussel. Prof. Ben Heijmen, Erasmus MC-Daniel den Hoed Cancer Center of Rotterdam, said "Additionally, dose to the healthy tissue can be strongly reduced using optimal and numerous non-coplanar beams when treating prostate cancer" comparing non-coplanar treatments to coplanar treatments. "There are non-adaptive and real-time adaptive solutions, but the only solution that adapts for target motion in real-time, available clinically, is the CyberKnife® System", added Dr. Iciar Santa Olalla. About Accuray
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV